Calian Group Earnings Calls
| Release date | Aug 13, 2026 |
| EPS estimate | $0.636 |
| EPS actual | - |
| Revenue estimate | 152.697M |
| Revenue actual | - |
| Expected change | +/- 2.91% |
| Release date | May 14, 2026 |
| EPS estimate | $0.700 |
| EPS actual | $0.94 |
| EPS Surprise | 33.57% |
| Revenue estimate | 155.103M |
| Revenue actual | 164.505M |
| Revenue Surprise | 6.06% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.666 |
| EPS actual | $0.750 |
| EPS Surprise | 12.61% |
| Revenue estimate | 147.947M |
| Revenue actual | 151.466M |
| Revenue Surprise | 2.38% |
| Release date | Nov 26, 2025 |
| EPS estimate | $0.607 |
| EPS actual | $1.27 |
| EPS Surprise | 109.23% |
| Revenue estimate | 205.156M |
| Revenue actual | 145.677M |
| Revenue Surprise | -28.99% |
Last 4 Quarters for Calian Group
Below you can see how CLNFF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 26, 2025 |
| Price on release | $37.39 |
| EPS estimate | $0.607 |
| EPS actual | $1.27 |
| EPS surprise | 109.23% |
| Date | Price |
|---|---|
| Nov 20, 2025 | $33.53 |
| Nov 21, 2025 | $33.53 |
| Nov 24, 2025 | $33.53 |
| Nov 25, 2025 | $33.53 |
| Nov 26, 2025 | $37.39 |
| Nov 28, 2025 | $37.39 |
| Dec 01, 2025 | $37.39 |
| Dec 02, 2025 | $37.39 |
| Dec 03, 2025 | $40.46 |
| 4 days before | 11.51% |
| 4 days after | 8.21% |
| On release day | 0% |
| Change in period | 20.67% |
| Release date | Feb 12, 2026 |
| Price on release | $52.10 |
| EPS estimate | $0.666 |
| EPS actual | $0.750 |
| EPS surprise | 12.61% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $45.90 |
| Feb 09, 2026 | $45.90 |
| Feb 10, 2026 | $45.90 |
| Feb 11, 2026 | $45.90 |
| Feb 12, 2026 | $52.10 |
| Feb 13, 2026 | $52.10 |
| Feb 17, 2026 | $53.53 |
| Feb 18, 2026 | $55.06 |
| Feb 19, 2026 | $57.58 |
| 4 days before | 13.51% |
| 4 days after | 10.51% |
| On release day | 0% |
| Change in period | 25.45% |
| Release date | May 14, 2026 |
| Price on release | $60.00 |
| EPS estimate | $0.700 |
| EPS actual | $0.94 |
| EPS surprise | 33.57% |
| Date | Price |
|---|---|
| May 08, 2026 | $51.89 |
| May 11, 2026 | $51.89 |
| May 12, 2026 | $50.92 |
| May 13, 2026 | $49.92 |
| May 14, 2026 | $60.00 |
| May 15, 2026 | $58.40 |
| May 18, 2026 | $58.40 |
| May 19, 2026 | $58.40 |
| May 20, 2026 | $58.42 |
| 4 days before | 15.63% |
| 4 days after | -2.63% |
| On release day | -2.67% |
| Change in period | 12.58% |
| Release date | Aug 13, 2026 |
| Price on release | - |
| EPS estimate | $0.636 |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 04, 2026 | $58.88 |
| Aug 05, 2026 | $58.47 |
| Aug 06, 2026 | $57.26 |
| Aug 07, 2026 | $57.26 |
| Aug 10, 2026 | $59.04 |
Calian Group Earnings Call Transcript Summary of Q1 2026
Calian reported a strong start to FY2026 with record Q1 results: revenue of $208M (up 12% YoY, 6% organic) and adjusted EBITDA of $23M (up 28%), driving adjusted EBITDA margin to 11% and gross margin to ~34%. Backlog stands at ~$1.4B with $171M in new signings in the quarter, including two Space antenna contracts >$35M and a >$30M ground-station contract. The company reorganized from four reporting segments into two (Defense & Space ~2/3 of revenue; Essential Industries ~1/3) to align with market demand and accelerate integrated solutions. Defense & Space momentum is driven by European NATO-related activity, growing Canadian defense engagement, and targeted investments (talent, infrastructure, tech). Essential Industries grew ~20% this quarter (supported by AMS and Infield Scientific acquisitions) and returned to modest organic growth. Cash flow from operations was $7M; operating free cash flow was $16M (69% cash conversion). Net debt is $102M (net debt / adjusted EBITDA ~1.2x) with ~ $250M of additional liquidity available from cash, unused facility and accordion. Capital deployment: ~$18M acquisition-related payments, $2M capex, $3M dividends; M&A remains the top capital priority, while the share buyback is temporarily paused. Fiscal 2026 outlook unchanged: targeting midterm annual revenue growth of 10–15% and adjusted EBITDA growth to outpace revenue; expecting double-digit revenue and adjusted EBITDA growth for FY26 vs FY25. Management expects margins to continue improving through the year and to exit at double-digit levels, while remaining disciplined on capital allocation and opportunistic on buybacks.
Sign In
Buy CLNFF